OAPI oversees commercial activities in the U.S. with a focus on developing products in neuroscience, oncology, and cardio-renal. It is our goal to deliver the most efficient, effective medicines, and the best value to our customers.
PRESIDENT & CEO
Kabir assumed the role of President & CEO of Otsuka North America Pharmaceuticals in March 2016. Prior to this position, Kabir worked as the Senior Vice President of Virology US Pharmaceuticals for Bristol-Myers Squibb.